In a recent study published in the Journal of Urology, Aminsharifi et al. sought to determine the diagnostic utility of PSA density (i.e., an ‘alternative test’) in detecting clinically significant prostate cancer in men with elevated PSA who underwent prostate biopsy [6]. The gene discussed is KLK3; the disease is prostate carcinoma.